A recent Relentless Health Value podcast shifts the spotlight on what Health and Human Services’ (HHS) rebate proposal could mean for pharmaceutical companies and pharmacy benefit managers.
The podcast features Capital Rx CEO Anthony Loiacono.
“Since any middleman who gets himself involved in any flowchart of this sort takes a buck, there is a massive landgrab opportunity that all these heretofore hidden players are battling over,” a description of the podcast states.
To listen to the full podcast, click here.
